Gut–Brain Axis and Amlapitta (Hyperacidity): A Review of Jatharagni Modulation and Microbial Homeostasis via Ayurvedic Detoxification

Authors

  • Randhir Kaushal Associate Professor, Department of Panchkarma, Government Ayurveda College, Sikar, Rajasthan, India Author
  • Sudha Sharma Principal, Shri Vinod Durgadutt Tibrewala Institute of Ayurveda Medical College and Hospital, Jhunjhunu, Rajasthan, India. Author

Keywords:

Amlapitta, Functional Dyspepsia, Gut–Brain–Microbiome Axis, Jatharagni, Pittadhara Kala Sahayo Majjadhara, Kala Axis, Samsarjana Krama, Shodhana, Virechana

Abstract

Functional dyspepsia is a highly prevalent disorder of gut–brain interaction under the Rome IV classification, characterized by post-prandial fullness, early satiety, epigastric pain, and burning. Traditional treatments often rely on acid-suppressive therapies that can induce long-term dysbiosis. In contrast, Ayurveda describes this clinical spectrum as Amlapitta, a pathology of the Annavaha Srotas (gastrointestinal tract) driven by Jatharagnimandya (depressed central metabolic fire) and the qualitative vitiation of Pachaka Pitta (specifically, increases in Dravatva and Amlatva). This review explores the structural and functional convergence between the classical Ayurvedic principle of Pittadhara Kala Sahayo Majjadhara Kala and the modern gut–brain–microbiome (GBM) axis. We evaluate how traditional Ayurvedic biopurification (Shodhana), specifically therapeutic emesis (Vamana) and purgation (Virechana), acts as a biological “reset” of the GBM axis. By analyzing classical Samhita literature, clinical symptomatology, and herbo-mineral pharmacology (Sutshekhar Rasa, Kamadudha Rasa, Avipattikar Churna, and Amlapitta Mishran Suspension), we present an evidence-based, integrative therapeutic paradigm. Furthermore, we outline how the graduated post-purification dietary protocol (Samsarjana Krama) functions as a structured prebiotic reconstruction algorithm that stabilizes short-chain fatty acid-producing bacterial cohorts, repairs mucosal barrier tight junctions, and restores autonomic gut–brain communication.

References

1. Tiwari RR, Pandey B. Pittadhara kala sahayo majjadhara kala and brain gut microbiota axis: A comparative review study. J Ayurveda. 2022;16(3):245-51. doi: 10.4103/joa.joa_290_20

2. Talley NJ, Ford AC. Functional dyspepsia. N Engl J Med. 2015;373:1853-63. doi: 10.1056/nejmra1501505

3. Rhee SH, Pothoulakis C, Mayer EA. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol. 2009;6(5):306-14. doi: 10.1038/ nrgastro.2009.35

4. Sanger GJ, Broad J. Vagal control of gastric motility and its role in functional dyspepsia. Gastroenterol Res Pract. 2018;2018:1-12. doi: 10.1155/2018/3826012

5. Chaturvedi A. A clinical study on Virechana Karma (therapeutic purgation) over the gut flora with special reference to obesity. Ayu. 2019;40:179-84. doi: 10.4103/ayu.ayu_302_19

6. Sthana K. Kashyapa samhita. Ch. 16. Varanasi: Chaukhambha Visvabharati; 2008.

7. Gaikwad KB, Bhojani MK. Systematic correlation of Ayurvedic Agni with modern metabolic science: A scoping review. Int J Community Med Public Health. 2026;13:1553-61.

8. Singh V, Rao M. Agni (digestive factor) and gut microbiota: Bridging ancient ayurvedic knowledge with contemporary science. Int J Ayurvedic Med. 2026;17(1):32-7. doi: 10.47552/ijam.v17i1.6388

9. Singh V, Rao MV. Seasonal regimen (Ritucharya) with special reference to Agni and gut microbiota. Int J Ayurvedic Med. 2024;15(S1):157-63. doi: 10.47552/ijam.v15iS1.5588

10. Naram S, Mahajan D, Parekh H. A randomized, open labelled, controlled equivalence pilot drug trial to evaluate effect of polyherbal formulations, efficacy and safety of modified Panchakarma treatment plan Obetox in patients with obesity (Medorog). J Ayurvedic Herb Integr Med. 2024;5(2):112-21.

11. Srivastava A, Nigam R, Mishra M. A review article on samsarjana karma. J Ayurveda Integr Med Sci. 2026;11(2):343-8.

12. Chaturvedi A. Effect and mechanism of Virechana Karma (therapeutic purgation) over fructose-induced metabolic syndrome: An experimental study. J Evid Based Complement Alternat Med. 2016;21(3):194-201. doi: 10.1177/2156587215596283

13. Vaidya JT, editor. Sutra sthana 24/22. In: Charaka samhita of agnivesha. Varanasi: Chaukhambha Prakashan; 2011. p. 125.

14. Vaidya JT, editor. Nidana sthana 4/8. In: Charaka samhita of agnivesha. Varanasi: Chaukhambha Prakashan; 2013. p. 213.

15. Koli PG, Shetty Y, Sharma R, Sevatkar BK, Pathrikar AA, Paradkar HS. A prospective, multi-centre, open label, single arm study to evaluate the efficacy and safety of Amlapitta Mishran Suspension in participants with Amlapitta (symptomatic gastritis). Pharmacogn J. 2025;17(5):545-51. doi: 10.5530/pj.2025.17.68

16. Sharma K, Paul S, Swami K, Rajput DS, Kumar S. Critical review of sootashekhara rasa. J Ayurveda. 2019;13(1):121-33.

17. Chauhan G, Mahapatra A, Kumar A. Study on clinical efficacy of Avipattikar Choorna and Sutasekhar Rasa in the management of urdhwaga Amlapitta. J Pharm Sci Innov. 2015;4(1):44-8. doi: 10.7897/2277-4572.0414

18. Singh D, Mal N, Kumar V, Sharma RP, Pareek P. Scientific explanation of mode of action of Kamadudha Rasa in Amlapitta with special reference to acid peptic disorders: A review. J Ayurveda Integr Med Sci. 2023;8(4):99-105. doi: 10.21760/jaims.8.4.17

19. Gupta S, Shailajan S. Pharmacological evaluation of herbo-mineral formulation Sutshekhar Rasa in acid peptic disorders. Ayurdhara. 2023;13(1):12-9. doi: 10.47070/ayushdhara.v13i1.2411

20. Patil S, Shah S. Preparation, quality control and stability studies of Avipattikar Churna. J Drug Deliv Thera. 2019;9(3-s):531-6. doi: 10.22270/jddt.v9i3-s.2911

Downloads

Published

2026-07-09

Issue

Section

REVIEW ARTICLE